✨ Onyx Summary Lexicon Pharmaceuticals announced that management will participate in fireside chats at Citi’s Biopharma Back to School Conference on September 3, 2025, and the H.C. Wainwright Global Investment Conference on September 8, 2025, with live webcasts available on the company’s investor site. The events provide Lexicon
✨ Onyx Summary Avidity Biosciences announced that its management team will participate in fireside chats at three upcoming investor conferences: the Cantor Global Healthcare Conference (Sept. 3), the Wells Fargo Healthcare Conference (Sept. 4), and the Morgan Stanley Global Healthcare Conference (Sept. 8). The sessions will provide updates on the company’
✨ Onyx Summary Recursion Pharmaceuticals announced participation in two upcoming investor conferences: the Citi 2025 BioPharma Back to School Conference on September 3, 2025, and the Morgan Stanley 23rd Annual Global Healthcare Conference on September 8, 2025. The company’s engagement underscores its strategy to highlight progress in scaling its Recursion
✨ Onyx Summary Belite Bio announced that its executive team will present at three major upcoming investor conferences in early September, including Cantor, Morgan Stanley, and H.C. Wainwright. Each presentation will be webcast and available for replay on the company’s investor relations website. These appearances highlight growing investor interest
✨ Onyx Summary enGene Holdings announced its participation in three upcoming investor conferences in September 2025, including the Wells Fargo Healthcare, H.C. Wainwright Global Investment, and Morgan Stanley Global Healthcare conferences. Management will present company updates and discuss progress on detalimogene voraplasmid, its lead non-viral gene therapy candidate for high-risk
✨ Onyx Summary Geron Corporation announced it will participate in a fireside chat at the 2025 Wells Fargo Healthcare Conference in Boston on September 4, 2025, with a live webcast accessible on its investor website. The appearance highlights Geron’s investor engagement strategy as it advances commercialization of RYTELO® and progresses
✨ Onyx Summary Foghorn Therapeutics (Nasdaq: FHTX) announced its participation in three upcoming investor events - Citi’s 2025 Biopharma Back to School Summit, the Wells Fargo Healthcare Conference, and the Morgan Stanley Global Healthcare Conference - where management will engage in one-on-one meetings with investors. The company continues to advance
✨ Onyx Summary Legend Biotech announced that CEO Ying Huang, Ph.D., will participate in a fireside chat at the Morgan Stanley Global Healthcare Conference on September 9, 2025. The event will be webcast live via the company’s investor relations site as Legend continues to expand its CAR-T leadership and
✨ Onyx Summary Perspective Therapeutics announced participation in multiple investor conferences in September 2025, including fireside chats and panel discussions at the Cantor Global Healthcare, Morgan Stanley Global Healthcare, and OPCO Targeted Radiopharmaceutical Therapies Summits in New York. The company’s leadership will engage with investors and industry peers to discuss
✨ Onyx Summary MassBio’s 2025 Industry Snapshot revealed the first biopharma job losses in Massachusetts R&D and manufacturing in years, driven by a sharp drop in venture funding, sluggish IPOs, and federal policy uncertainty. Yet with unmatched scientific talent, a dense innovation ecosystem, and renewed state support, the
✨ Onyx Summary Seer, Inc. (Nasdaq: SEER) will participate in the Morgan Stanley 23rd Annual Global Healthcare Conference on September 9, 2025, featuring a fireside chat at 12:20 p.m. ET. A live webcast and replay will be accessible on the company’s investor website. On August 26, 2025, Seer
✨ Onyx Summary ImmunityBio announced early pilot data in recurrent glioblastoma showing that all five patients treated with its combination of ANKTIVA® (an IL-15 agonist), NK cell therapy, and Optune Tumor Treating Fields achieved disease control, including two near-complete responses. Glioblastoma is among the most aggressive brain cancers, with limited treatment
✨ Onyx Summary Guardant Health will present in a fireside chat at the Morgan Stanley 23rd Annual Global Healthcare Conference on September 8, 2025—an appearance that underscores its prominence as a leader driving the future of precision oncology and cancer screening innovation. PALO ALTO, Calif.– Guardant Health, Inc. (Nasdaq: GH)
✨ Onyx Summary Piramal Pharma Limited released its FY2025 Sustainability Report, detailing measurable progress across governance, climate action, diversity, and community impact under its four sustainability pillars. The report highlights a 6% cut in Scope 1 and 2 emissions, expanded renewable energy use to 20%, and strengthened DE&I representation,
✨ Onyx Summary Phathom Pharmaceuticals announced that its management team will present at the Cantor Global Healthcare Conference on September 3 and the H.C. Wainwright Global Investment Conference on September 8, 2025, with live webcasts and replays available on the company’s website. Management will also participate in one-on-one investor
✨ Onyx Summary Kyverna Therapeutics announced that CEO Warner Biddle will participate in fireside chats at the 2025 Wells Fargo, Morgan Stanley, and H.C. Wainwright Global Healthcare Conferences in early September. The presentations will be webcast live via Kyverna’s investor relations website, with replays available for 90 days. EMERYVILLE,
